Explore articles, research, and perspectives from the International Perfusion Association.
A post hoc PRO-TAVI analysis explores coronary disease complexity, PCI timing, and bleeding in 466 TAVR patients. Subgroup findings require confirmation.
A 17-centre registry analysis of 502 redo mitral operations through right minithoracotomy reports 7.6% in-hospital mortality and 3% conversion to sternotomy. Compared with cardioplegia,
A randomized trial in Nepal compared pulsatile and non-pulsatile cardiopulmonary bypass in elective atrial septal defect closure and mitral valve replacement. Among 77 analyzed
A retrospective cohort of 200 adults describes normothermic cardiopulmonary bypass guided by indexed flow, cerebral oximetry, and oxygen delivery, with vasopressors reserved for clinical
A Colombian study of 179 adults undergoing isolated aortic valve replacement found lower modeled costs with Del Nido than Custodiol cardioplegia. Thirty-day survival was
This population-based study evaluated quality indicators for transcatheter aortic valve implantation (TAVI) among 9,748 procedures at 11 Ontario hospitals. Five measurable indicators showed generally
This case report describes a 69-year-old woman who developed thrombotic obstruction of a mitral bioprosthesis while receiving VA-ECMO with left ventricular venting after complex
This study evaluated mitral transcatheter edge-to-edge repair (M-TEER) in advanced heart failure patients who might otherwise have been reasonable candidates for left ventricular assist
This retrospective study of 3,313 patients undergoing mitral valve surgery found that women presented older, with more advanced heart failure, and were less likely
This clinical case report details the rescue of a critically ill patient with malignancy-induced tricuspid obstruction and cardiopulmonary collapse. A large intracardiac mass was
This retrospective cohort study compares survival outcomes and surgical efficiency between minimally invasive mitral valve surgery (MiMVS) via mini-thoracotomy and conventional sternotomy. Among 422
This study presents 5-year outcomes from the Evolut Low Risk trial, comparing transcatheter aortic valve replacement (TAVR) with surgery in low-risk patients with severe
